Intelligent Medication Management System

Publication ID: 24-11857325_0003_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Medication Management System,” Published Technical Disclosure No. 24-11857325_0003_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857325_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,325.

Summary of the Inventive Concept

A comprehensive medication management system integrating AI, IoT, blockchain, and wearable technologies to monitor and assess a user's physiological condition, medication adherence, and driving ability, providing personalized recommendations and secure data sharing with healthcare providers.

Background and Problem Solved

The original patent disclosed a device and system for monitoring the use of a medical device and assessing a user's impairment in relation to driving a vehicle. However, it lacked the integration of advanced technologies to provide a more holistic and accurate assessment of a user's medication regime and driving ability. The new inventive concept addresses this limitation by incorporating synergistic combinations of AI, IoT, blockchain, and wearable technologies to create a more powerful and comprehensive system.

Detailed Description of the Inventive Concept

The Intelligent Medication Management System consists of a wearable device monitoring a user's physiological condition, an injection monitoring device measuring dosing information, and a blockchain-based platform for secure data storage and sharing with authorized healthcare providers. The system integrates an AI-powered analytics module to predict the user's impairment level based on the monitored physiological condition and dosing information. Additionally, the system can transmit a driving ability assessment to a vehicle's IoT-enabled system for restricting or enabling vehicle operation. The system also includes a cloud-based platform for integrating the monitored physiological condition and dosing information to provide personalized medication recommendations and a 3D printing module for generating customized medication containers with embedded RFID tags for tracking medication adherence.

Novelty and Inventive Step

The new claims introduce the integration of AI, IoT, blockchain, and wearable technologies to create a more comprehensive and accurate system for managing a medication regime and assessing a user's driving ability. The inventive step lies in the synergistic combination of these technologies to provide a more holistic approach to medication management and driving safety.

Alternative Embodiments and Variations

Alternative embodiments of the Intelligent Medication Management System could include the integration of other advanced technologies, such as natural language processing or computer vision, to further enhance the system's capabilities. Variations of the system could be designed for specific disease states or medication types, or for use in different settings, such as hospitals or clinics.

Potential Commercial Applications and Market

The Intelligent Medication Management System has significant commercial potential in the healthcare industry, particularly in the fields of medication management, patient safety, and digital health. The system could be marketed to pharmaceutical companies, healthcare providers, and patients with chronic diseases, offering a comprehensive solution for managing medication regimes and ensuring safe driving practices.

Field of Art

Medical device management systems, specifically medication tracking and driving safety assessment technologies involving physiological monitoring, IoT integration, and data analytics

Person of Ordinary Skill (PHOSITA) Profile

A skilled practitioner with expertise in medical device engineering, IoT systems, data analytics, and healthcare technology integration, typically holding a graduate degree in biomedical engineering, computer science, or related field with 3-5 years of industry experience

Obviousness Rationale

A person having ordinary skill in the art would recognize that the PTD's disclosed variations represent predictable extensions of the source patent's core medication monitoring and driving assessment framework. The additional technologies like AI, blockchain, and IoT represent known techniques for enhancing medical monitoring systems. The systematic integration of these technologies follows established design patterns for improving medical device tracking and user safety assessment.

Obvious Combinations & Variations

Source Patent Element
Injection monitoring device measuring dosing information
PTD Variation
AI-powered analytics module predicting user impairment level based on dosing information
Obviousness Reasoning
Applying machine learning to medical monitoring data is a known technique for extracting predictive insights, representing an obvious improvement to existing monitoring systems
Source Patent Element
Medical monitoring device configured to assess driving ability
PTD Variation
Blockchain-based platform for securely storing and sharing physiological and dosing information
Obviousness Reasoning
Implementing secure data storage and sharing is a predictable solution for managing sensitive medical monitoring data, utilizing standard blockchain technology integration techniques
Source Patent Element
System for communicating user's driving ability level
PTD Variation
IoT-enabled vehicle system for automatically restricting or enabling vehicle operation based on impairment assessment
Obviousness Reasoning
Automated vehicle access control based on medical monitoring represents a logical extension of existing driving safety technologies, using well-established IoT integration methods
Source Patent Element
Injection device monitoring system
PTD Variation
3D printed medication containers with embedded RFID tracking for medication adherence
Obviousness Reasoning
Combining additive manufacturing with tracking technologies is a known approach for improving medication management, representing an obvious design optimization
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857325 and the disclosed technical variations, a person having ordinary skill in the art would find the claimed innovations obvious. The systematic integration of AI, blockchain, IoT, and advanced tracking technologies represents predictable improvements to existing medication monitoring and driving safety assessment systems, thereby rendering subsequent claims obvious under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,325
TitleDevice for managing a medication regime
Assignee(s)Sanofi